bupivacaine hydrochloride monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial AUST R: 11314Active ingredients:
bupivacaine hydrochloride monohydrate
Dosage form: Injection, solution
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
From 25 Sep 2023 to 31 May 2024
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: An alternative generic product is available.
|
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule AUST R: 11312Active ingredients:
bupivacaine hydrochloride monohydrate
Dosage form: Injection, solution
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
From 11 Mar 2024 to 31 May 2024
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: Alternative products are available.
|
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (100mg/20mL) injection BP vial AUST R: 12725Active ingredients:
bupivacaine hydrochloride monohydrate
Dosage form: Injection, solution
Sponsor: Pfizer Australia Pty Ltd
Phone: 1800-675-229
|
Deletion from market:
31 Jan 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|